Central Michigan University College of Medicine, Mount Pleasant, USA.
University of Minnesota/Masonic Children's Hospital, Minneapolis, USA; University of California at Davis, Sacramento, USA.
J Electrocardiol. 2021 Jul-Aug;67:98-102. doi: 10.1016/j.jelectrocard.2021.05.014. Epub 2021 Jun 1.
Pediatric patients who receive pacemakers may have a lifetime of repeat exposure to fluoroscopy. His bundle pacing may provide better long-term pacing for these patients. To minimize fluoroscopy and for improved localization of the His bundle, we utilized three-dimensional mapping to guide His bundle pacing and we follow-up short-term results.
An Octapolar Livewire catheter (Abbott, Minneapolis, USA) was used for mapping and location of the His bundle while 3-dimensional mapping via the EnSite Precision system (Abbott Medical, Abbott Park, IL) was utilized to create a 3-dimensional geometry. The EnSite Precision system also mapped and recorded His bundle signal strengths and earliest ventricular activation or retrograde His bundle activation.
Three patients are presented and followed for 4-5 months. The ages ranged from 10 to 15 years with 1 male patient. Diagnoses including progressive atrioventricular block, alternating bundle branch block and atrioventricular canal defect with complete heart block. All patients received selective His-bundle pacing systems. The range in fluoroscopy time was 6.4 to 9.9 min with 5.64 mGy to 10.18 mGy. Stable lead thresholds, impedances and sensing were present at last follow-up.
His bundle pacing in our 3 pediatric patients including one with altered His-bundle physiology (case 3 with atrioventricular canal defect) was successful with good short-term follow-up results.
接受起搏器治疗的儿科患者可能会在一生中多次接受透视检查。希氏束起搏可能为这些患者提供更好的长期起搏。为了尽量减少透视检查并提高希氏束定位的准确性,我们利用三维标测引导希氏束起搏,并随访短期结果。
使用八极 Livewire 导管(美国雅培公司)进行希氏束标测和定位,同时利用 EnSite Precision 系统(美国雅培医疗,伊利诺伊州雅培公园)进行三维标测,以创建三维几何结构。EnSite Precision 系统还可以标测和记录希氏束信号强度以及最早的心室激活或逆行希氏束激活。
介绍了 3 名患者,并随访了 4-5 个月。年龄从 10 岁到 15 岁不等,其中有 1 名男性患者。诊断包括进行性房室传导阻滞、交替束支传导阻滞和房室管缺陷伴完全性心脏阻滞。所有患者均接受了选择性希氏束起搏系统治疗。透视时间范围为 6.4 至 9.9 分钟,剂量为 5.64 至 10.18 毫戈瑞。最后一次随访时,导线阈值、阻抗和感知稳定。
我们对 3 名儿科患者(包括 1 名希氏束生理学改变的患者[病例 3 为房室管缺陷])进行了希氏束起搏,结果成功,短期随访结果良好。